Efficacy and safety of 400 and 800 mg etodolac versus 1000 mg paracetamol in acute treatment of migraine: a randomized, double-blind, crossover, multicenter, clinical trial

被引：0
|
作者：
Ozturk, V. [1 ]
Ertas, M. [2 ]
Baykan, B. [3 ]
Sirin, H. [4 ]
Ozge, A. [5 ]
机构：
[1] Dokuzeylul Uni, Izmir, Turkey
[2] Anadolu Hlth Ctr, Istanbul, Turkey
[3] Istanbul Uni, Istanbul, Turkey
[4] Aegean Uni, Izmir, Turkey
[5] Mersin Uni, Mersin, Turkey
来源：
CEPHALALGIA | 2011年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS1-14
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [41] Topiramate versus amitriptyline for migraine prophylaxis: a multicenter, randomized, double-blind, parallel treatment group trial
    Dodick, D.
    Silberstein, S.
    Freitag, F.
    Ruoff, G.
    Banks, J.
    Saper, J.
    Xiang, J.
    Finlayson, G.
    Biondi, D.
    Greenberg, S. J.
    Hulihan, J. F.
    [J]. CEPHALALGIA, 2006, 26 (11) : 1373 - 1373
  • [42] Topiramate versus amitriptyline for migraine prophylaxis: A multicenter, randomized, double-blind, parallel treatment group trial
    Dodick, David
    Silberstein, Stephen
    Freitag, Frederick
    Ruoff, Gary
    Banks, James
    Saper, Joel
    Xiang, Jim
    Finlayson, Gar
    Rupnow, Marcia
    Biondi, David
    Greenberg, Steven
    Hulihan, Joseph
    [J]. NEUROLOGY, 2007, 68 (12) : A367 - A367
  • [43] Randomized double-blind trial comparing the efficacy and tolerability of almotriptan and zolmitriptan in the acute treatment of migraine
    Goadsby, P. J.
    Massiou, H.
    Cabarrocas, X.
    Pascual, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 195 - 195
  • [44] A randomized, double-blind crossover trial of paracetamol 1000 mg four times daily vs ibuprofen 600 mg:: effect on swelling and other postoperative events after third molar surgery
    Bjornsson, GA
    Haanæs, HR
    Skoglund, LA
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 405 - 412
  • [45] Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Yu, Shengyuan
    Ran, Ye
    Wan, Qi
    Yang, Xiaosu
    Chen, Huisheng
    Wang, Hebo
    Hu, Xueqiang
    Mao, Shanping
    Yu, Tingming
    Luo, Guogang
    Guan, Yangtai
    Gao, Xuguang
    Li, Xin
    Zhou, Muke
    Li, Yu
    [J]. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2019, 25 (12) : 1215 - 1224
  • [46] Double-Blind, Placebo Controlled, Randomized Clinical Trial Comparing Melatonin 3 mg, Amitriptyline 25 mg and Placebo for Migraine Prevention
    Peres, Mario
    Goncalves, Andre
    [J]. NEUROLOGY, 2013, 80
  • [47] FAMOTIDINE VERSUS CIMETIDINE IN THE TREATMENT OF ACUTE DUODENAL-ULCER - DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL COMPARING NOCTURNAL ADMINISTRATION OF 40 MGFAMOTIDINE TO 800 MG CIMETIDINE
    HARTMANN, H
    FOLSCH, UR
    [J]. DIGESTION, 1988, 39 (03) : 156 - 161
  • [48] Double-Blind, Placebo Controlled, Randomized Clinical Trial Comparing Melatonin 3 mg, Amitriptyline 25 mg and Placebo for Migraine Prevention
    Peres, M. F. P.
    Goncalves, A. L.
    Ribeiro, R. T.
    [J]. CEPHALALGIA, 2013, 33 (S8) : 94 - 95
  • [49] Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study
    Bulut, S
    Berilgen, MS
    Baran, A
    Tekatas, A
    Atmaca, M
    Mungen, B
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 107 (01) : 44 - 48
  • [50] A randomized, double-blind, placebo-controlled study of oral almotriptan 6.25 mg, 12.5 mg, and 25 mg in the acute treatment of migraine in adolescents
    Linder, S. L.
    Mathew, N. T.
    Cady, R. K.
    Finlayson, G.
    Ishkanian, G.
    Lewis, D. W.
    Cabarrocas, X.
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S152 - S152
12345